Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been acquired by Amgen (NASDAQ: AMGN).

Alumis is firmly in focus after announcing positive topline results from two Phase 3 trials (ONWARD1 and ONWARD2) evaluating envudeucitinib , its next-generation oral TYK2 inhibitor, in ...

GLP-1 drugs like semaglutide and tirzepatide have rewritten the rules of weight loss and diabetes care, but the story turns ...

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...

Even if you think you learned everything that you needed to know way back in biology class, everyone has knowledge gaps. And ...

Fish & Richardson has elevated 18 new principals, effective January 1, 2026. This accomplished group exemplifies the firm's longstanding commitment to developing leaders who combine legal excellence ...

Grab-and-go missions to asteroids have provided some of the most scientifically valuable samples since the Apollo ...

The CBSE Class 12 Biology exam is scheduled for March 27, 2026. Experts advise students to focus on key topics like Genetics, ...

WNC Fallon campus student Richard Gomez, who was completing his Associate of Science degree work during fall semester and ...

Study uncovers key insights about how a new class of antiviral drugs works. Cryo-EM images showed the drugs bound to herpes simplex virus (HSV) protein at nearly atomic detail, while optical tweezers ...

Starting next academic session, Delhi schools will admit children to Class 1 only after they turn six. The Directorate of Education (DoE) notified this change on October 24. This is in accordance with ...